Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://immuneel.com/sitemap_index.xml # --------------------------- # END YOAST |
Title | Immuneel Therapeutics Private |
Description | Immuneel is bringing breakthrough cancer treatment to India. Immuneel is bringing breakthrough cancer treatment to India. Affordably. Cell, gene and immunotherapy are at the frontier of cancer treatment, offering real hope to millions. In the few countries, where cell therapies are available, these are very |
Keywords | N/A |
WebSite | immuneel.com |
Host IP | 45.113.122.143 |
Location | India |
Site | Rank |
US$2,328,888
Last updated: 2023-05-18 13:26:22
immuneel.com has Semrush global rank of 4,544,790. immuneel.com has an estimated worth of US$ 2,328,888, based on its estimated Ads revenue. immuneel.com receives approximately 268,718 unique visitors each day. Its web server is located in India, with IP address 45.113.122.143. According to SiteAdvisor, immuneel.com is safe to visit. |
Purchase/Sale Value | US$2,328,888 |
Daily Ads Revenue | US$2,150 |
Monthly Ads Revenue | US$64,493 |
Yearly Ads Revenue | US$773,908 |
Daily Unique Visitors | 17,915 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
immuneel.com. | A | 900 | IP: 45.113.122.143 |
immuneel.com. | NS | 900 | NS Record: ns2.7domainbrains.net. |
immuneel.com. | NS | 900 | NS Record: ns1.7domainbrains.net. |
immuneel.com. | MX | 3600 | MX Record: 0 immuneel-com.mail.protection.outlook.com. |
immuneel.com. | TXT | 3600 | TXT Record: MS=ms35363663 |
immuneel.com. | TXT | 3600 | TXT Record: v=spf1 ip4:144.208.69.162 +a +mx +ip4:216.194.164.28 +ip4:144.208.70.218 +include:spf.protection.outlook.com -all |
Company Science The India Story Partners Investors & Media Press Releases Careers Company Purpose Leadership Scientific Advisory Board Our approach Science Cell & gene therapies Cellular immunotherapies R&D roadmap The India Story Patients are waiting India, a crucible Bridging the gap Partners Investors & Media Press Releases Careers FAQ Contact Cookie policy Terms of use, Privacy Policy & Disclaimers Immuneel is bringing breakthrough cancer treatment to India. Affordably. Cell, gene and immunotherapy are at the frontier of cancer treatment, offering real hope to millions. In the few countries, where cell therapies are available, these are very expensive, and access is limited. Immuneel, led by a group of healthcare visionaries across US & India, is making cell therapies affordable and accessible in India, for India. On a mission for India Leadership Our Approach Using immune cells to fight cancer Immuneel is pioneering cell and gene therapies such as Chimeric Antigen Receptor T cell |
HTTP/1.1 301 Moved Permanently Date: Wed, 22 Jun 2022 08:28:39 GMT Server: Apache Expires: Wed, 22 Jun 2022 09:28:42 GMT Cache-Control: max-age=3600 X-Redirect-By: WordPress Upgrade: h2,h2c Connection: Upgrade Location: https://immuneel.com/ Vary: User-Agent Referrer-Policy: no-referrer-when-downgrade Content-Type: text/html; charset=UTF-8 |
Domain Name: IMMUNEEL.COM Registry Domain ID: 2399158013_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.enom.com Registrar URL: http://www.enomdomains.com Updated Date: 2022-05-06T13:55:30Z Creation Date: 2019-06-06T03:26:14Z Registry Expiry Date: 2023-06-06T03:26:14Z Registrar: eNom, LLC Registrar IANA ID: 48 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.7DIGITALSOLUTIONS.IN Name Server: NS1.7DOMAINBRAINS.NET Name Server: NS2.7DIGITALSOLUTIONS.IN Name Server: NS2.7DOMAINBRAINS.NET DNSSEC: unsigned >>> Last update of whois database: 2022-06-22T08:23:53Z <<< |